Priyanka Dhomse, Mumbai The IDMA (Indian Drug Manufacturers' Association) Nutraceutical Subcommittee organised a conference - Product Registration Under FSSAI - Knowhow & Challenges here on Friday. The conference was aimed at both the nutraceutical ... FnBnews.com, 1 week ago
Nutraceutical Subcommittee of IDMA is organizing 2 days conference in Mumbai - PharmaBiz, 1 month ago
IDMA to organise seminar and panel discussion at iPHEX 2013 - PharmaBiz, 1 month ago
See all (54) images for "indian drug manufacturers association"
Indian protesters lift a balloon shaped like a pill during a demonstration against the Swiss drug manufacturer Novartis, in Mumbai on December 21, 2012. India's top court denied Monday a patent request by Swiss drug giant Novartis in a landmark ...MSN Philippines, 1 month ago Ruling thrills patients and boosts Indian generic drug makers SmartPlanet, 2 weeks ago PITTS: When generics win, patients lose Washington Times, 2 weeks ago India's ruling in drug case lifeline for cancer patients East African, 1 month ago
Suja Nair Shirodkar, Mumbai Top drug regulators from across the globe are expected to meet the Indian drug manufacturers and regulators in Mumbai to discuss and deliberate over export potential of the country, while addressing the regulatory issues ...PharmaBiz, 1 month ago
The new drug price control order (DPCO 2013) notified by the government of India evoked a mixed response from the industry and the pharmaceutical trade. The Indian Pharmaceutical Association (IPA) Tamil Nadu branch secretary J Jayaseelan said the ...PharmaBiz, 13 hours ago New DPCO may hit the prospects of MNCs, may force withdraw some products from market PharmaBiz, 1 day ago New drug policy to impact multinational firms more Financial Chronicle, 1 day ago Retd regulators blame it on regulators' apathy for unjustifiable prices of drugs fixed by MNCs & big cos PharmaBiz, 1 month ago
To address the issues related to drugs and other pharmaceutical products and also to ensure the quality of medicines manufactured and supplied, separate directorate of pharmacy (ED) should be established in each state under health departments.PharmaBiz, 3 days ago Imports Threaten to Drive Out Local Drug Producers Individual.com, 2 weeks ago India Pushes Back Deadline for Barcodes on Primary Drug Packages Again In-Pharmatechnologist, 1 month ago Guj pharma exporters seek govt subsidy to implement compulsory barcoding Smart Investor, 1 month ago
NASHVILLE, Tenn., May 16 The Tennessee Attorney General issued the following news release: Generic drug maker Ranbaxy will pay Tennessee more than $5.5 million as part of a $500 million agreement resolving claims the company sold inferior drugs and ...Pharmacy Choice, 3 days ago Drugmaker Ranbaxy fined $500 million Punjabkesari, 1 week ago Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA TradingCharts.com, 1 week ago Subsidiary of Indian drug maker agrees to pay record $500 million US penalty for impure drugs News 1130, 1 week ago
The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans. FORTUNE -- On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss ...CNN Money, 5 days ago The epic inside story of fraud at a generic Lipitor giant Fortune, 6 days ago Fraud at a generic Lipitor giant CNN Money, 6 days ago Colombia unveils report for UN human rights review Colombia Reports, 1 month ago
AG Gansler Announces $500M National Settlement in Medicaid Fraud Case Pharmaceutical manufacturer in India resolves impure drugs claims
Attorney General Douglas F. Gansler announced today that Maryland has joined with 49 other states and the federal government in a $500 million settlement to resolve civil and criminal allegations that Ranbaxy, a generic pharmaceutical manufacturer ...Individual.com, 6 days ago
Novartis India headquarters in Mumbai. Photo:REUTERS Headlines have been trumpeting the Indian Supreme Court's decision to deny a new patent for the cancer drug Gleevec as an attack on intellectual property rights and a win for patients in need of ...Bangladesh Daily Star, 1 week ago World needs high patent standards Business Daily Africa, 1 week ago India Shows U.S. Path to Patent Standards Cato Institute, 1 week ago
With the U.S. Food and Drug Administration (FDA) adhering to tougher import norms, a group of U.S.-based Indian-American scientists is now helping Indian pharmaceutical companies sharpen their knowledge and maintain competitiveness. These scientists ...The Hindu, 1 week ago
on your WebpageAdd Widget >Get your members hooked!